ANN ARBOR, Mich., Sep 19, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) today announced that Gerald D. Brennan, Jr., Vice President, Administrative & Financial Operations and Chief Financial Officer, will present at the UBS Global Life Sciences Conference.

ANN ARBOR, Mich., Sep 13, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) today announced that Sheldon A. Schaffer, Ph.D., Vice President, Corporate Development & Intellectual Property, will present at the Merriman Curhan Ford & Co.

ANN ARBOR, Mich., Sep 10, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a regenerative medicine company, today reported financial results for the fourth quarter and fiscal year ended June 30, 2007. The Company also reported clinical and operational

ANN ARBOR, Mich., Sep 04, 2007 (BUSINESS WIRE) -- Aastrom Biosciences, Inc. (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences, Inc. 4th Quarter Fiscal Year 2007 Investor Conference Call When: Monday, September 10, 2007 @ 4:30 pm (EDT) Where:

Adult Stem Cell Company Slated for Growth in Ann Arbor Township

Five Sites Initiated for Phase IIb Trial in U.S.

Company Achieves Multiple Clinical Milestones; Initiates Several Clinical Trials

Patient-Specific Stem Cell Trial to Address Unmet Medical Need

ANN ARBOR, Mich., May 03, 2007 (BUSINESS WIRE) -- Aastrom Biosciences, Inc. (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences, Inc. 3rd Quarter Fiscal Year 2007 Investor Conference Call When: Tuesday, May 8, 2007 @ 9:00 am (EDT) Where:

FDA-Approved Phase IIb Trial Underway in U.S. to Treat Critical Limb Ischemia